Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
9 - If we put a BRC regarding a patient program regarding our product in the product package, do we have to send the patient program for PAAB review?
-
You should check with Health Canada regarding "labeling" requirements when you add information to the product package or inside the package. Some companies choose to send these BRC's to Health Canada as labeling. If Health Canada accepts them, they are exempt from PAAB review. If not, it would usually be a promotional item subject to PAAB review. You can check with us. Remember federal labeling requirements apply to sample packaging.
